Intellia Therapeutics
NTLA
#5139
Rank
ยฃ0.98 B
Marketcap
ยฃ9.69
Share price
0.83%
Change (1 day)
-59.30%
Change (1 year)

Revenue for Intellia Therapeutics (NTLA)

Revenue in 2024 (TTM): ยฃ33.71 Million

According to Intellia Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ34.27 Million. In 2023 the company made a revenue of ยฃ28.47 Million a decrease over the revenue in the year 2022 that were of ยฃ43.08 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Intellia Therapeutics from 2015 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ33.71 M18.42%
2023 ยฃ28.47 M-33.91%
2022 ยฃ43.08 M75.94%
2021 ยฃ24.48 M-42.45%
2020 ยฃ42.54 M29.44%
2019 ยฃ32.87 M37.1%
2018 ยฃ23.97 M24.07%
2017 ยฃ19.32 M44.7%
2016 ยฃ13.35 M227.45%
2015 ยฃ4.07 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA